Clinical Trials Directory

Trials / Conditions / Ovarian Epithelial Cancer Recurrent

Ovarian Epithelial Cancer Recurrent

11 registered clinical trials studyying Ovarian Epithelial Cancer Recurrent.

StatusTrialSponsorPhase
CompletedPressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian T
NCT02735928
Catholic University of the Sacred HeartN/A
CompletedBioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
NCT02260544
Dr. Reddy's Laboratories LimitedPhase 1
CompletedMifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid T
NCT02014337
Corcept TherapeuticsPhase 1
CompletedPankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer
NCT01899599
Glycotope GmbHPhase 2
CompletedBevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
NCT01735071
Mario Negri Institute for Pharmacological ResearchPhase 2
CompletedRetrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD
NCT02394015
Grupo Español de Investigación en Cáncer de Ovario—
UnknownA Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovari
NCT01715168
Azaya Therapeutics, Inc.Phase 1
UnknownSurgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
NCT01611766
Shanghai Gynecologic Oncology GroupPhase 3
Active Not RecruitingHyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
NCT01376752
UNICANCERPhase 3
CompletedIPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer
NCT01588964
Catholic University of the Sacred HeartPhase 2
CompletedA Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
NCT02026921
Nordic Society of Gynaecological Oncology - Clinical Trials UnitPhase 2